Who owns CHEMOMAB THERAPEUTICS LTD?
- Ticker: CMMB
- CUSIP Number: 16385c104
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 2.2M | $1.1M | 0% | Dec 2023 |
|
| Ikarian Capital | 213k | $109k | 0% | Dec 2023 |
|
| Two Sigma Investments | 56k | $29k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 35k | $18k | 100% | Dec 2023 |
|
| Citadel Advisors | 33k | $17k | 100% | Dec 2023 |
|
| Kestra Private Wealth Services | 31k | $16k | 0% | Dec 2023 |
|
| Virtu Financial | 26k | $13k | 100% | Dec 2023 |
|
| Millennium Management | 20k | $10k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 19k | $9.5k | 555% | Dec 2023 |
|
| Advisor Group Holdings | 585.00 | $297.004500 | -67% | Dec 2023 |
|
| Moser Wealth Advisors | 500.00 | $255.000000 | 0% | Dec 2023 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Newbridge Financial Services Group | Sep 2023 | 1.1k | $985.050000 |